Company: STAA
Filing Date: 2025-08-29
Form Type: PREM14A
Source: 0001193125-25-192889
Chunk: 87

Company: STAAR SURGICAL CO
Filing Date: 2025-08-29
Form: PREM14A
Chunk 87
---
 committee. In rendering its opinion, Citi assumed and relied, without independent verification, upon the accuracy and completeness of all financial and other information and data publicly available or provided to or otherwise reviewed by or discussed with Citi and upon the assurances of the management of STAAR that they were not aware of any relevant information that has been omitted or that remained undisclosed to Citi. With respect to financial forecasts and other information and data relating to STAAR provided to or otherwise reviewed by or discussed with Citi, Citi was advised by the management of STAAR, and Citi assumed, with the Board’s consent, that such forecasts and other information and data were reasonably prepared in good faith on bases reflecting the best currently available estimates and judgments of the management of STAAR as to, and are a reasonable basis -53-

upon which to evaluate, the future financial performance of STAAR. Citi also assumed, with the Board’s consent, that the financial results reflected in such financial forecasts and other
information and data utilized in its analyses would be realized in the amounts and at the times projected. Citi expressed no view or opinion as to any financial and other information or data (or any underlying assumptions on which any such financial
and other information or data are based) provided to or otherwise reviewed by or discussed with Citi.

Citi assumed, with the
Board’s consent, that the Merger would be consummated in accordance with the terms, conditions and agreements set forth in the Merger Agreement, and in compliance with all applicable laws, documents and other requirements, without waiver,
modification or amendment of any material term, condition or agreement and that, in the course of obtaining the necessary governmental, regulatory or third party approvals, consents, and releases for the Merger, no delay, limitation, restriction or
condition would be imposed or occur that would have an adverse effect on STAAR or the Merger (including the contemplated benefits thereof) or that otherwise would be meaningful in any respect to its analyses or opinion. Representatives of STAAR
advised Citi, and Citi further assumed, that the final terms of the Merger Agreement would not vary, in any material respect, from those set forth in the draft reviewed by Citi. Citi did not make and was not provided with an independent evaluation
or appraisal of the assets or liabilities (contingent, derivative, off-balance sheet, accrued or otherwise) of STAAR or any other business or person, nor did Citi make any physical inspection of the properties